JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
PTGX - Protagonist Therapeutics, Inc.
USD | NASDAQ | Healthcare
Summary
Summary PTGX Stock
Financials
Financials PTGX Stock
Loading...
Loading...
Income Statement
Income Statement PTGX Stock
Balance Sheet
Balance Sheet PTGX Stock
Cash Flow Statement
Cash Flow Statement PTGX Stock
Loading...
Loading...
PTGX Financials - Protagonist Therapeutics Income & Cash Flow | Ledgeburg
Home
Stocks
Protagonist Therapeutics, Inc. (PTGX)
Financials
Financials of PTGX
Loading...
Loading...
Loading...
Loading...
Revenue
$46.016M
Operating Income
$-158.127M
Net Income
$-130.149M
Share Count (Basic)
63.573048M
Operating Cash Flow
$57.671M
Free Cash Flow
$56.081M
Cash And Short-Term Equivalents
$567.364M
Total Debt
N/A
Annual
Quarterly
Revenue $USD
0
100M
200M
300M
400M
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
20M
40M
60M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
Annual
Quarterly
Net Income $USD
-100M
0
100M
200M
300M
Annual
Quarterly
Margins
Gross
Operating
Net
-400%
-200%
0%
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-30M
-20M
-10M
0
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1000%
-800%
-600%
-400%
-200%
0%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26